Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutants

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9890152
APP PUB NO 20160016948A1
SERIAL NO

14745159

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to novel compounds which are inhibitors of T790M containing EGFR mutants, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the prevention or treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GENENTECH, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bryan, Marian C San Francisco, US 24 120
Chan, Bryan San Carlos, US 29 775
Elliott, Richard Leonard Harlow, GB 14 27
Hanan, Emily Redwood City, US 23 237
Heald, Robert Harlow, GB 25 499
Heffron, Timothy Burlingame, US 33 467
Knight, Jamie Harlow, GB 11 35
Lainchbury, Michael Harlow, GB 18 54
Purkey, Hans Burlingame, US 3 11
Seward, Eileen M Harlow, GB 9 129

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 13, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 13, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00